BGHL (GBP): FINAL NAV(s)   BOUSSARD GAVAUDAN HOLDING

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
20
BGHL (GBP): FINAL NAV(s)

 

BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

 

Close of business 30/04/2018.

 

Final NAV

 

  Euro Shares Sterling Shares
Final NAV €  23.6442 £  20.9409
Final MTD return  -0.58 %  -0.50 %
Final YTD return  0.85 %  1.12 %
Final ITD return  136.44 %  109.41 %

 

NAV and returns are calculated net of management and performance fees

 

 

For further information please contact:

 

Boussard & Gavaudan Investment Management, LLP.

Emmanuel Gavaudan +44 (0) 20 3751 5389       Email    : info@bgam-uk.com

 

The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.

This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

Neither the Company nor BG Fund ICAV has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.

You should always bear in mind that:

all investment is subject to risk;

results in the past are no guarantee of future results;

the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and

if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice.

 

This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.

 

 

 

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Era for Small Cell Lung Cancer: Breakthroughs & Challenges

Updated Category News Views 39

Unpacking Small Cell Lung Cancer Progress These days, it feels like we're standing on the brink of something real big in the fight against small cell lung cancer. And I'm not talking about pie-in-the-sky ideas—there are some serious game changers coming down the pike, folks. You see, in the past, this aggressive cancer type was pretty much a death sentence. But thanks...

Continue Reading
Beta Bionics Lawsuit: What Investors Need to Know

Updated Category News Views 43

Beta Bionics Takes a Hit: What's Behind the Drop? You ever have one of those moments where you wonder if you missed a memo? Well, folks investing in Beta Bionics (NASDAQ:BBNX) sure might feel that way after a staggering 37% plunge in their stock. The issue here isn't just the drop—it's what spurred it: a securities class action lawsuit alleging some murky disclosures...

Continue Reading
Gildan Faces Investor Class Action After Stock Tumbles

Updated Category News Views 15

Shake-Up at Gildan: Investors Take Legal Action Gildan Activewear Inc. (NYSE:GIL) got themselves in hot water, folks. They've landed on the wrong side of an investor class action lawsuit after claims of shady business tactics sent their stock plummeting like a rock in June. We're talking about an 18.75% nosedive here. That's not just a slip—it's a fall worth wearing a...

Continue Reading
US State Dept. & IICA: Strengthening Disaster Response

Updated Category News Views 65

Bridging Borders to Tackle Disasters It seems like everyone and their grandma talks disaster aid, but when two giants like the US State Department's Bureau of Disaster and Humanitarian Response (DHR) and the Inter-American Institute for Cooperation on Agriculture (IICA) grab a coffee—real serious action is brewing. Why This Matters The partnership's not just talk. Let's...

Continue Reading
Ferrovial's 2026 Growth: North America Drives Success

Updated Category News Views 0

Solid Gains Across the Board Right off the bat, Ferrovial's 2026 report card screams 'win'. For the first three quarters, they clocked in a hefty 21.8% boost in adjusted EBITDA, and revenue didn't dawdle either, climbing 10.8%—not exactly a stroll in the park to accomplish. North America's No Joke Ferrovial's got a clear hero in their narrative and it's North America....

Continue Reading
Webull Faces Class Action: Deadline Looms Dec 2026

Updated Category News Views 25

Sinking Shares: The Webull Saga Unfolds Shady business practices can really make a stock take a nosedive, and that's what's happening with Webull Corporation, trading under NASDAQ:BULL. The alarm bells started ringing when the truth about their operations and ties to China came out. Turns out, what looked like a stable American fintech platform had its roots digging deep...

Continue Reading
Coulomb Solutions Powers Ahead with ReadyGrid Launch

Updated Category News Views 90

Breaking New Ground with ReadyGrid If you've been keeping an eye on the energy storage landscape, today's a big day. Coulomb Solutions, Inc. (CSI) is shaking things up by spinning off ReadyGrid, its own dedicated mobile energy storage powerhouse. The move is designed to tackle the pressing power challenges that have been nagging industries across the board, from...

Continue Reading
CTCA Tackles Trust Issues in $B-illion Card Market

Updated Category News Views 68

Gaps in a Booming Industry Trading cards might sound like kid stuff, but don’t be fooled—there's billions riding on paper and ink these days. Yet, a dark cloud hovers over the trading card scene, where questions of transparency and accountability loom large. Digital repacks and those dicey randomized packs have folks questioning what’s in the mix: Is it a safe bet...

Continue Reading
Tempo's Protein Max Meals: A High-Protein Revolution

Updated Category News Views 85

Packed Protein, Zero Hassle Every once in a while, something comes along in the food sector that changes the game. Tempo's Protein Max meals might just be it. Launching with a hefty 40 grams of protein in every serving, these meals promise a powerful punch for anyone who's serious about meeting their protein counts without spending hours in the kitchen. Two minutes flat...

Continue Reading
Doximity Lawsuit: What Investors Need to Know Now

Updated Category News Views 56

Lawsuit Clouds Hang Over Doximity The courtroom isn't typically where you find stocks making headlines, but Doximity's recent plunge isn't just a market hiccup. After a rough patch, an alleged misstep lands them squarely under the legal microscope, and investors have questions. Tracing Doximity's Rocky Financial Reports First, let's rewind to November last year. Doximity...

Continue Reading

Top 5 Most Recently Viewed Articles

Deadline Approaching for Five9, Inc. Investors: Act Now

Updated Category News Views 125

Important Update for Five9, Inc. Investors Recent developments have brought Five9, Inc. into the spotlight as investors are reminded of a crucial deadline concerning a securities fraud class action lawsuit. If you have holdings in Five9, Inc. (NASDAQ: FIVN), understanding your rights and options is paramount, especially with the deadline for filing approaching. Investors...

Continue Reading
Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook

Updated Category News Views 146

Overview of Bioretec Ltd's Financial Adjustments Bioretec Ltd announced major revisions to its previously reported first-half financial figures. The company acknowledged an adjustment related to its sales and distribution contract with Tri-State Biologics (TSB), a key aspect of its operational strategy. Understanding the TSB Distribution Agreement The initial TSB...

Continue Reading
Insights on Unemployment Trends and Federal Reserve Predictions

Updated Category News Views 252

Recent Analysis of U.S. Job Market Trends A recent report highlights a decline in unemployment rates within the U.S. labor market, suggesting possible changes in interest rate policies from the Federal Reserve. Economists are predicting that during the Fed's upcoming meeting, a rate cut of 0.25% may be on the table. Such a move could ease some economic pressures without...

Continue Reading
Protect Yourself from Ghost Tax Preparers This Tax Season

Updated Category News Views 111

Beware of Ghost Tax Preparers and Their Tactics The California Tax Education Council (CTEC) has issued a warning to taxpayers to remain vigilant as fraudulent ghost tax preparers continue to deceive unsuspecting clients. These tax preparers often promote themselves with promises of significant refunds and low fees, but they typically vanish soon after the tax deadline,...

Continue Reading
BTQ Technologies Enhances Leadership with Dr. Sean Kwak's Expertise

Updated Category News Views 322

BTQ Technologies Welcomes Dr. Sean Kwak as Strategic Advisor BTQ Technologies Corp. (CBOE CA: BTQ, FSE: NG, OTCQX: BTQQF), known for its focus on quantum technology, recently announced a significant addition to its leadership team. Dr. Sean Kwak, recognized as one of the foremost authorities in applied quantum technology in Korea, will step into the role of Strategic...

Continue Reading